In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...

And Zepbound participants saw their waists reduced by an average 7.2 in (18.4 cm), compared with 5.1 in (13 cm ... the maximum dose of Zepbound 10 mg or 15 mg to 1.7 mg or 2.4 mg in semaglutide.

GLP-1 drug Zepbound leads to greater weight and waist loss than Wegovy in 72-week trial, say researchers at European Congress ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.